Tag - drug discovery

From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

Tempus Announces the Acquisition of Paige

The Critical Link Between CROs and Sponsors: Making Data Work for You

Neither AI nor ChatGPT Will Save Your Drug Discovery Pipeline …

Rewiring Precision Medicine: How AI Is Transforming Science and Business

Germany Calls for a Policy Shift to Address their Country’s Aging Population

Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

2024 in Review

TLDR; The Value of Drugs for Rare Disease Indications May Be Higher Than You Think – Assets for Neurodevelopmental Disorders Alone May Be Worth Beyond USD $420B.

Novel Genetic Priority Score (GPS) Unveiled to Enhance Target Prioritization in Drug Development

L7 Informatics Manages and Supports the Entire Lab Workflow from Sample Processing to Data Analysis and Insight Generation Employing Workflow Orchestration

ONTOFORCE Wants to Increase Data Literacy and Empower Citizen Data Scientists

Deepcell Aims to Create a Single Cell Morpholome Platform

We Invite you to join enlightenbio’s Subject Matter Expert Network!

Copyright © 2026. enlighenbio LLC. All rights reserved.